HanAll Biopharma Announces Orphan Drug Designation for Batoclimab in Japan for Active Thyroid Eye Disease
HanAll Biopharma Co., Ltd. (KRX: 009420.KS), a global biopharmaceutical company committed to discovering and developing ...
Zacks.com on MSN7h
Argenx (ARGX) Surges 4.1%: Is This an Indication of Further Gains?
Argenx (ARGX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...
Le Lézard9h
Soleo Health Introduces New Ambulatory Infusion Suite in Fort Wayne
Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today the opening of its ambulatory infusion suite (AIS) in Fort Wayne, further expanding its ...
Investing.com Australia12h
Bernstein double upgrades Argenx to "outperform," raises price target to €755
Argenx (NASDAQ: ARGX) has been upgraded to an "outperform" rating from "underperform" by Bernstein, with the price target revised sharply upwards to €755 from 1 ...
Rheumatology Advisor7h
Reports of Hypersensitivity Prompt Withdrawal of Certain Immune Globulin Products
Several lots of IGIV and IGSC have been voluntarily withdrawn due to increased reports of allergic/hypersensitivity type reactions.